Blocking Bitterness

Drowning bitter-tasting pharmaceuticals in sweeteners or dispersing them into liposomes, microcapsules, or gums are standard ways to get people to swallow medications such as antibiotics, cold remedies, and ulcer medications. Cranbury, NJ-based Linguagen is developing a new approach using the signal transduction pathways that underlie taste: The company is screening libraries of small, natural molecules to be used as additives that would block the binding of bitter-tasting compounds before the b

By | June 7, 2004

<p/>

Drowning bitter-tasting pharmaceuticals in sweeteners or dispersing them into liposomes, microcapsules, or gums are standard ways to get people to swallow medications such as antibiotics, cold remedies, and ulcer medications. Cranbury, NJ-based Linguagen is developing a new approach using the signal transduction pathways that underlie taste: The company is screening libraries of small, natural molecules to be used as additives that would block the binding of bitter-tasting compounds before the brain registers the unpleasant experience. According to a press release, regulatory clearance for the first of the company's blockers is anticipated "shortly."

Applications of altering ability to taste bitter chemicals are eclectic. "Agonizing a sweet receptor could amplify the perception of sweetness of nutritional sweeteners," says Shawn Marcell, CEO of Linguagen; such an application could reduce sugar content of a carbonated beverage by 90%. And blocking bitterness isn't restricted to making an antibiotic that a kid won't spit out. He adds, "The bitterness in soy milk is covered up with sugar, defeating the healthy purpose. We are looking to improve that."

"It's better to specifically inhibit the bitter taste," says Robert Margolskee, professor of physiology and biophysics at the Mt. Sinai School of Medicine, who discovered the signaling pathway behind taste.

The ability to taste bitter substances is probably adaptive, as many toxic plants bear distasteful alkaloids. "Avoiding poisonous foods could have made the difference between sickness and survival during evolution," suggests Stephen D. Roper, professor of physiology and biophysics at the University of Miami School of Medicine.

- Ricki Lewis

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Streakers, Poopers, and Performers: The Wilder Side of Wildlife Cameras
AAAS